375 related articles for article (PubMed ID: 28531231)
1. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
[TBL] [Abstract][Full Text] [Related]
2. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
[TBL] [Abstract][Full Text] [Related]
4. Application of IFN-γ/IL-2 FluoroSpot assay for distinguishing active tuberculosis from non-active tuberculosis: A cohort study.
Zhang L; Wan S; Ye S; Cheng X; Zhang Y; Shi X; Zhou B; Sun X; Liu X
Clin Chim Acta; 2019 Dec; 499():64-69. PubMed ID: 31454491
[TBL] [Abstract][Full Text] [Related]
5. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
6. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
7. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet's disease.
Wu X; Chen P; Wei W; Zhou M; Li C; Liu J; Zhao L; Zhang L; Zhao Y; Zeng X; Liu X; Zheng W
BMC Infect Dis; 2019 Apr; 19(1):323. PubMed ID: 30987605
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
11. IL-6 release of Rv0183 antigen-stimulated whole blood is a potential biomarker for active tuberculosis patients.
Liu Y; Li X; Liu W; Liu Y; Zhong Z; Wang L; Ge S; Zhang J; Xia N
J Infect; 2018 Apr; 76(4):376-382. PubMed ID: 29174965
[TBL] [Abstract][Full Text] [Related]
12. Activation Phenotype of
Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
Front Immunol; 2021; 12():721013. PubMed ID: 34512645
[TBL] [Abstract][Full Text] [Related]
13. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
14. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
[TBL] [Abstract][Full Text] [Related]
15. Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.
Chesov D; Lange C; Daduna F; Crudu V; Preyer R; Ernst M; Kalsdorf B
PLoS One; 2015; 10(3):e0120006. PubMed ID: 25785445
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
[TBL] [Abstract][Full Text] [Related]
17. High IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis.
Carrère-Kremer S; Rubbo PA; Pisoni A; Bendriss S; Marin G; Peries M; Bolloré K; Terru D; Godreuil S; Bourdin A; Van de Perre P; Tuaillon E
PLoS One; 2016; 11(9):e0162137. PubMed ID: 27603919
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the characteristics of the enzyme-linked immunospot assay for diagnosis of active tuberculosis in China.
Wang L; Yu Y; Chen W; Feng J; Wang J; Zhao H; Ma L; Yang B; Ma Y; Dang P
Clin Vaccine Immunol; 2015 May; 22(5):510-5. PubMed ID: 25739918
[TBL] [Abstract][Full Text] [Related]
20. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
